ATE500275T1 - Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten - Google Patents

Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten

Info

Publication number
ATE500275T1
ATE500275T1 AT06806796T AT06806796T ATE500275T1 AT E500275 T1 ATE500275 T1 AT E500275T1 AT 06806796 T AT06806796 T AT 06806796T AT 06806796 T AT06806796 T AT 06806796T AT E500275 T1 ATE500275 T1 AT E500275T1
Authority
AT
Austria
Prior art keywords
april
antibodies
aprily
patients
lympho
Prior art date
Application number
AT06806796T
Other languages
English (en)
Inventor
Bertrand Huard
Lars French
Olivier Donze
Maximilien Murone
Original Assignee
Enzo Life Sciences Els Ag
Univ Geneve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzo Life Sciences Els Ag, Univ Geneve filed Critical Enzo Life Sciences Els Ag
Application granted granted Critical
Publication of ATE500275T1 publication Critical patent/ATE500275T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06806796T 2005-09-26 2006-09-22 Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten ATE500275T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05020881 2005-09-26
PCT/EP2006/066625 WO2007039489A1 (en) 2005-09-26 2006-09-22 Antibodies against april as biomarkers for early prognosis of lymphoma patients

Publications (1)

Publication Number Publication Date
ATE500275T1 true ATE500275T1 (de) 2011-03-15

Family

ID=35636771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06806796T ATE500275T1 (de) 2005-09-26 2006-09-22 Antikörper gegen april als biomarker zur frühen prognose in lymphompatienten

Country Status (9)

Country Link
US (1) US8609821B2 (de)
EP (1) EP1934258B1 (de)
JP (1) JP5227174B2 (de)
AT (1) ATE500275T1 (de)
AU (1) AU2006298794B2 (de)
CA (1) CA2623530C (de)
DE (1) DE602006020467D1 (de)
IL (1) IL190401A0 (de)
WO (1) WO2007039489A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140155411A1 (en) * 2012-04-13 2014-06-05 Somalogic, Inc. Tuberculosis Biomarkers and Uses Thereof
WO2014124280A1 (en) * 2013-02-08 2014-08-14 Institute For Myeloma & Bone Cancer Research Improved diagnostic, prognostic, and monitoring methods for multiple myeloma, chronic lymphocytic leukemia, and b-cell non-hodgkin lymphoma
NL2011406C2 (en) * 2013-09-06 2015-03-10 Bionovion Holding B V Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptides.
NL2014108B1 (en) 2015-01-09 2016-09-30 Aduro Biotech Holdings Europe B V Altered april binding antibodies.
EP3245230B1 (de) * 2015-01-15 2020-12-16 Université Grenoble Alpes Anti april (a proliferation-inducing ligand) antikörper und deren verwendung zur prognose und/oder diagnose von krebs
US20170145086A1 (en) 2015-11-25 2017-05-25 Visterra, Inc. Antibody molecules to april and uses thereof
TW202440636A (zh) 2023-03-21 2024-10-16 美商傳記５５有限公司 Ｃｄ１９／ｃｄ３８多特異性抗體

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL339463A1 (en) 1997-09-12 2000-12-18 Biogen April - novel protein of growth promoting action
US7189820B2 (en) * 2001-05-24 2007-03-13 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (APRIL)

Also Published As

Publication number Publication date
AU2006298794A1 (en) 2007-04-12
US8609821B2 (en) 2013-12-17
HK1112630A1 (en) 2008-09-12
EP1934258B1 (de) 2011-03-02
US20110143367A1 (en) 2011-06-16
JP2009509948A (ja) 2009-03-12
JP5227174B2 (ja) 2013-07-03
EP1934258A1 (de) 2008-06-25
IL190401A0 (en) 2008-11-03
CA2623530C (en) 2015-02-03
AU2006298794B2 (en) 2012-05-10
WO2007039489A1 (en) 2007-04-12
DE602006020467D1 (de) 2011-04-14
CA2623530A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
IL190401A0 (en) Antibodies against april as biomarkers for early prognosis of lymphoma patients
RU2007139912A (ru) Способ прогнозирования течения рака на основе количественного анализа клеточного рецептора витамина фолата
AR063125A1 (es) Ensayo elisa para la deteccion de vegf
RU2010126620A (ru) Vegf полиморфизм и анти-ангиогенезная терапия
EA201190041A1 (ru) Человеческие аутоантитела против альфа-синуклеина
WO2009132058A3 (en) Levels of bcma protein expression on b cells and use in diagnostic methods
EA200901436A1 (ru) Антигенсвязывающие белки, связывающие par-2
UA90082C2 (ru) Выделенное моноклональное антитело человека, которое специфически связывается с cd25 человека и ингибирует связывание il-2 с cd25
RU2015104579A (ru) Диагностические анализы и наборы для детекции фолатного рецептора 1
PH12012501006A1 (en) Compositions and methods relating to anti-igf-1 receptor antibodies
DE60228557D1 (de) Candida-nachweis
WO2005108989A3 (en) Assay for antibodies
WO2008012362A3 (en) New protein isoforms and uses thereof
DK2054443T3 (da) Antistoffer mod en epitop fra AGR2, assays og hybridomer
BRPI0815460A2 (pt) kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
EA200702361A1 (ru) АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ
Zhang et al. Label-free biosensor for non-invasive and low-cost detection of metastatic risk through urine biopsy
Nagato et al. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy
Chen et al. Effects of acid stimulation on saliva flow rate and compositions of human parotid and submandibular glands
RU2008111144A (ru) Способы моделирования и ингибирования миграции раковых клеток
WO2003068268A3 (en) Treatment, diagnosis and imaging of disease
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
WO2004033628A3 (en) Use of monoclonal antibodies to distinguish protein conformational isoforms
Jiang et al. Alterations of GPI transamidase subunits in head and neck squamous carcinoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties